Absorica LD
- Product NDC
- 10631-005
- 11-digit product format
- 106310005
- Labeler code
- 10631
- Product ID
- 10631-005_fba81535-0761-42a7-b422-338f8bd2cfc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- isotretinoin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- NDA211913
- Marketing category
- NDA
- Marketing start
- 2019-11-20
- Substance
- ISOTRETINOIN
- Active strength
- 24 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211913-001 | ABSORICA LD | ISOTRETINOIN | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | |
| N211913-002 | ABSORICA LD | ISOTRETINOIN | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | |
| N211913-003 | ABSORICA LD | ISOTRETINOIN | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | |
| N211913-004 | ABSORICA LD | ISOTRETINOIN | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | |
| N211913-005 | ABSORICA LD | ISOTRETINOIN | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | |
| N211913-006 | ABSORICA LD | ISOTRETINOIN | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N211913-001 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-001 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | |
| N211913-002 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-002 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | |
| N211913-003 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-003 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | |
| N211913-004 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-004 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | |
| N211913-005 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-005 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | |
| N211913-006 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | |
| N211913-006 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-005 | ABSORICA LD | 28MG | CAPSULE / ORAL | RLD | 2019-11-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211913-006 | ABSORICA LD | 32MG | CAPSULE / ORAL | RLD, RS | 2019-11-05 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211913-001 | ABSORICA LD | 8MG | CAPSULE / ORAL | RLD | 2019-11-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211913-002 | ABSORICA LD | 16MG | CAPSULE / ORAL | RLD | 2019-11-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211913-003 | ABSORICA LD | 20MG | CAPSULE / ORAL | RLD | 2019-11-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211913-004 | ABSORICA LD | 24MG | CAPSULE / ORAL | RLD | 2019-11-05 | 2680178bc6a6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N211913-001 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-001 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-002 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-002 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-003 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-003 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-004 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-004 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-005 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-005 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-006 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211913-006 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-001 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-001 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-002 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-002 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-003 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-003 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-004 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-004 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-005 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-005 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-006 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211913-006 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-001 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-001 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-002 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-002 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-003 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-003 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-004 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-004 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-005 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-005 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-006 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211913-006 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-001 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-001 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-002 | 9750711 | 2035-05-29 | Drug product | 2019-11-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211913-002 | 9700535 | 2035-08-04 | Drug product | 2019-11-25 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Absorica LD
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ISOTRETINOIN | 24 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| EH28UP18IF | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197843 | Internal RxNorm lookup |
| 197844 | Internal RxNorm lookup |
| 197845 | Internal RxNorm lookup |
| 403930 | Internal RxNorm lookup |
| 1299203 | Internal RxNorm lookup |
| 1300006 | Internal RxNorm lookup |
| 1300014 | Internal RxNorm lookup |
| 1300016 | Internal RxNorm lookup |
| 1547561 | Internal RxNorm lookup |
| 1547563 | Internal RxNorm lookup |
| 1547565 | Internal RxNorm lookup |
| 1547567 | Internal RxNorm lookup |
| 2262711 | Internal RxNorm lookup |
| 2262713 | Internal RxNorm lookup |
| 2262714 | Internal RxNorm lookup |
| 2262715 | Internal RxNorm lookup |
| 2262717 | Internal RxNorm lookup |
| 2262719 | Internal RxNorm lookup |
| 2262721 | Internal RxNorm lookup |
| 2262723 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3ef0cff8-19c1-4441-b780-fca6c7ee1615 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8300c0f6-79a4-735b-88ec-d781bfffdb10 | Product name | 5 | 20260305 |
| 644afe93-ba9b-4043-8e40-a9fe9af2d5d7 | Product name | 2 | 20250616 |
| baf7f49c-75b6-496b-a00e-8e766a8e4f03 | Product name | 1 | 20210127 |
| e5fedfa5-6b96-4769-872b-95d1e7f3a85a | Product name | 1 | 20200415 |
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10631-005-31 | Absorica LD | 3 in 1 BOX | CAPSULE | 3 | 18 | |
| 10631-005-31 | Absorica LD | 10 in 1 BLISTER PACK | CAPSULE | 10 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10631-005-31 | EA - Each | 10631-005 | 1d0e1e13-900c-4720-85d5-2b4eef8fad71 | 1 | 2020-01-03 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Absorica LD | ISOTRETINOIN | Sun Pharmaceutical Industries, Inc. | 3ef0cff8-19c1-4441-b780-fca6c7ee1615 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 211913 NDA211913 10631-005 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 10631-005-31 | 10631000531 | 3 BLISTER PACK in 1 BOX (10631-005-31) / 10 CAPSULE in 1 BLISTER PACK | 3 blister pack | 2019-11-20 | 0000-00-00 | No | No | Current |